Skip to Content

Cyclosporine Oral Solution

Last Updated: May 8, 2020
Status: Current

Products Affected - Description
    • Cyclosporine oral solution, Teva, 100 mg/mL, 50 mL bottle, NDC 00172-7313-20
Reason for the Shortage
    • Teva has cyclosporine oral solution on shortage due to an active pharmaceutical ingredient delay.
    • Novartis has Neoral and SandImmune oral solutions available.
Available Products
    • Sandimmune oral solution, Novartis, 100 mg/mL, 50 mL bottle, NDC 00078-0110-22
    • Gengraf oral solution, AbbVie, 100 mg/mL, 50 mL bottle, NDC 00074-7269-50
    • Neoral oral solution, Novartis, 100 mg/mL, 50 mL bottle, NDC 00078-0274-22
    • Cyclosporine oral solution, Teva, 100 mg/mL, 50 mL bottle, NDC 00591-2224-55

Estimated Resupply Dates

    • Teva has cyclosporine modified oral solution (NDC 00172-7313-20) on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated May 8, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 24, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide